International Flavors & Fragrances Inc. (IFF) — ESG & Values Scores

Environment story

IFF demonstrates moderate environmental performance with significant governance strengths but material climate-related risks. The company discloses awareness of sustainability pressures and regulatory evolution (EU microplastics bans, REACH, TSCA, Chemicals Strategy for Sustainability) but does not publicly disclose Scope 1, 2, or 3 GHG emissions, net-zero targets, or verified decarbonization roadmaps in available filings. The 10-K risk factors acknowledge elevated climate and environmental regulatory risk but lack quantified emissions baselines or interim reduction milestones. The company faces supply-chain exposure to agricultural commodities (oils, botanicals) vulnerable to climate stress (drought, water scarcity), and operational exposure through specialized manufacturing sites. No evidence of greenwashing (carbon-offset reliance vs. operational cuts) is present in filings, but lack of transparency prevents scoring above moderate range. Environmental score penalized for undisclosed Scope 3 emissions and absent net-zero commitment (-15 each); credit given for acknowledgment of ESG focus and regulatory compliance infrastructure (+10 for stated initiatives).

Criticisms on file

No disclosed Scope 1, 2, or 3 GHG emissions or net-zero target in 10-K filings; lacks quantified climate commitments required for ESG scoring.
Source: IFF 10-K 2025, MD&A and Risk Factors sections; absence of emissions data and net-zero year in official filings.
Supply-chain vulnerability to climate shocks: company sources essential oils, botanical extracts, and agricultural chemicals globally; drought, floods, and water scarcity identified as material risks to input costs and production continuity.
Source: IFF 10-K 2025, Risk Factors: 'Trade wars, tariffs, sanctions, geopolitical developments, supply chain disruptions, environmental events, natural disasters, public health or human rights crises.'
Specialized manufacturing sites create concentration risk; some facilities are 'the sole location for producing certain products'; disruptions could force costly relocation or reformulation.
Source: IFF 10-K 2025, Risk Factors: 'Many of our manufacturing and research and development sites are highly specialized.'
Regulatory compliance costs rising but undefined; company states 'additional capital expenditure and other costs' required to meet new regulations (microplastics ban, CLP, TSCA updates) but does not disclose capex budget or timelines.
Source: IFF 10-K 2025, Risk Factors: 'If we are unable to comply with regulatory requirements and industry standards...'

Disclosed initiatives

Regulatory Compliance Infrastructure

Company acknowledges ongoing compliance with REACH, TSCA, EU microplastics ban, and evolving environmental regulations across jurisdictions.

Proactive adaptation to tightening environmental rules; operational changes underway but scope and investment level unspecified.
Sustainability Focus Recognition

10-K identifies 'customer, consumer, shareholder and regulatory focus on sustainability' as a material business factor; Board has designated sustainability expertise.

Governance-level acknowledgment of ESG materiality; operational translation and investment magnitude not disclosed.
Supply Chain Climate Risk Mitigation

Company maintains 'strategic stock levels' of raw materials and seeks alternative sourcing to mitigate supply disruptions from environmental and climate events.

Resilience measure; extent of substitution away from climate-vulnerable sourcing (e.g., essential oils, botanicals) not quantified.

Social story

IFF demonstrates solid social governance with robust board diversity (40% women, median tenure 3 years, strong skill matrix), absence of major documented labor strife, and formal executive-compensation alignment with performance. CEO-to-median-worker pay ratio not disclosed in proxy, preventing exact scoring; however, proxy shows no major union-suppression litigation or recent strikes in 10-K risk factors. Leadership diversity appears adequate (board includes women in chair and committee roles; executive team composition not detailed). Supply-chain audits and human-rights due diligence frameworks mentioned in risk disclosure but not comprehensively detailed; no evidence of unmitigated cobalt/lithium mining or forced-labor violations. Employee turnover concerns noted in risk factors ('inability to recruit, retain or transition employees') linked to ongoing strategic restructuring, which may elevate turnover risk. Social score reflects strong governance infrastructure with modest deduction for lack of disclosed pay-ratio transparency and supply-chain audit scope.

Criticisms on file

CEO-to-median-worker pay ratio not disclosed in proxy statement; prevents verification of pay equity and executive-to-worker compensation spread.
Source: IFF DEF 14A 2026 Proxy Statement; no CEO pay-ratio disclosure in 'Executive Compensation' or related sections.
Employee turnover and retention risk elevated due to ongoing strategic transformation, 2025 segment reorganization, and cost-reduction initiatives (IFF Productivity Program, severance costs $70M in 2025).
Source: IFF 10-K 2025, Risk Factors: 'Our inability to recruit, retain or transition employees could adversely affect our ability to compete'; MD&A: Restructuring charges $70M (2025) vs. $29M (2024).
Supply-chain human-rights audits and vendor code-of-conduct enforcement not comprehensively detailed; company acknowledges dependence on third-party compliance but states 'we do not control third parties and cannot guarantee compliance.'
Source: IFF 10-K 2025, Risk Factors: 'We could be adversely affected by violations...of...employment and human rights or employment regulations'; 'our reputation and customer relationships depend in part on compliance by our suppliers...with ethical employment practices.'
Active antitrust investigations in multiple jurisdictions and class-action lawsuits related to competition law; outcomes uncertain and may involve material fines or business restrictions.
Source: IFF 10-K 2025, Risk Factors: 'Our results of operations may be negatively impacted by...the ongoing antitrust and competition investigations and related class action lawsuits...we are currently subject to antitrust investigations in a number of countries.'

Disclosed initiatives

Board Diversity & Governance

10-member board with 40% women (Virginia Drosos, Cynthia Jamison, Dawn Willoughby); diverse professional backgrounds (retail, financial services, biotech, IBM, Harvard); non-executive Chair (Kevin O'Byrne); annual director elections; robust committee structure (Audit, Human Capital & Compensation, Governance & Corporate Responsibility, Innovation).

Strong board-level oversight and diversity of perspective; annual assessment process in place.
Pay-for-Performance Compensation

Proxy discloses annual equity grants, performance stock units, and incentive compensation tied to Adjusted Operating EBITDA and other financial metrics; clawback policy in place; no guaranteed increases or equity awards for NEOs.

Executive compensation aligned with shareholder value; transparency on performance measures.
Succession Planning & Talent Retention

Board maintains 'Formal Board and Executive Succession Planning'; proxy notes annual assessments; however, 10-K risk factors highlight ongoing challenges with employee retention during strategic transformation.

Governance framework for continuity; execution challenged by business restructuring and divestitures.
Sustainability & Human Capital Focus

Board Innovation Committee and Governance & Corporate Responsibility Committee include ESG oversight; company acknowledges 'human capital' as a skill area for director evaluation.

Board-level attention to social and talent risks; operational implementation not detailed.

Governance story

IFF exhibits strong governance architecture with high board independence (90%; 9 of 10 directors independent, all except CEO), annual director elections, non-executive chair, robust committee structure, proxy access by-laws, no dual-class share structure, and comprehensive risk oversight. Lobbying expenditures and PAC contributions not disclosed in proxy or 10-K; unable to assess lobbying targeting environmental deregulation or consumer-protection rollback. Active antitrust investigations and related class-action litigation represent material regulatory risk; 10-K discloses ongoing investigations in 'a number of countries' but lacks quantified estimate of potential fines or consent-decree obligations. No material SEC enforcement actions, privacy fines, or major antitrust-settlement disclosures identified in filings, though investigations remain active. Board has implemented clawback policy, share-retention guidelines, prohibition on hedging/short sales, and formal succession planning. Governance score reflects strong independence and structural controls, modest deduction for absence of lobbying transparency and active antitrust litigation risk.

Criticisms on file

Active antitrust investigations in multiple countries and class-action litigation in U.S. and Canada; 10-K discloses ongoing probes but does not quantify potential fines, settlement range, or probability of adverse outcome.
Source: IFF 10-K 2025, Risk Factors: 'Our results of operations may be negatively impacted by legal claims, disputes, investigations and litigation, including the ongoing antitrust and competition investigations and related class action lawsuits'; 'we are currently subject to antitrust investigations in a number of countries and class action lawsuits in the U.S. and Canada alleging antitrust violations.'
Lobbying expenditures and PAC contributions not disclosed in proxy statement or 10-K; unable to verify alignment with shareholder ESG priorities or absence of anti-environmental-regulation lobbying.
Source: IFF DEF 14A 2026 and 10-K 2025: no disclosure of annual lobbying spend or PAC contributions in searchable sections.
Goodwill impairment charges of $1.153 billion (2025), $64 million (2024), and $2.623 billion (2023) suggest material asset valuation risk and ongoing strategic misalignment; segment reorganization triggered additional impairment testing.
Source: IFF 10-K 2025, MD&A: 'Impairment of goodwill' line item; Note 12 Consolidated Statements of Income (Loss): Food Ingredients segment impairment $1.153B (2025).
Material debt outstanding ($5.994 billion as of Dec 31, 2025) with covenants limiting flexibility; dividend reduced ~50% in Feb 2024 to improve leverage ratios; share repurchases limited.
Source: IFF 10-K 2025, Risk Factors: 'We have a substantial amount of indebtedness that could materially adversely affect...our financial condition, our ability to return capital to shareholders'; Dividend section: 'we announced in February 2024 that we had updated its dividend policy, reducing the expected quarterly dividend approximately 50%.'

Disclosed initiatives

Board Independence & Leadership Structure

10-member board with 90% independence (9 of 10 directors); non-executive Chair Kevin O'Byrne; annual election of all directors; majority voting and director resignation policy in uncontested elections.

Strong independent oversight; leadership separation; shareholder alignment through frequent director accountability.
Robust Committee Structure

Audit Committee (Chair: Cynthia Jamison, Financial Expert); Human Capital & Compensation Committee (Chair: Dawn Willoughby); Governance & Corporate Responsibility Committee (Chair: Mehmood Khan); Innovation Committee (Chair: Mehmood Khan). Committee membership detailed; financial expertise designated.

Specialized oversight of audit, executive compensation, ESG/governance, and innovation risks.
Executive Compensation Governance

Clawback policy in place; no guaranteed pay increases or equity awards for NEOs; stock retention guidelines; prohibition on hedging, short sales, pledges of company stock by executives and directors.

Alignment of executive incentives with long-term shareholder value; mitigation of speculative trading risk.
Shareholder Rights & Proxy Access

Proxy access by-law permits eligible shareholders (3% ownership, 3-year hold) or group of up to 20 to nominate up to 20% of board for proxy inclusion. Shareholder right to call special meeting. No exclusive forum or fee-shifting provisions. Annual director nominations permitted via shareholder proposal.

Shareholder influence on director selection; no litigation barriers or cost-shifting.
Risk Management Oversight

Board conducts annual risk assessment; committees address audit, compliance, ESG, and enterprise risks; annual board and committee self-assessment process.

Systematic identification and monitoring of material risks; governance evolution based on annual feedback.
Formal Succession Planning

Board maintains formal board and executive succession planning; annual assessments per proxy governance guidelines.

Continuity planning for CEO and senior roles; documented governance of leadership transitions.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of International Flavors & Fragrances Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open International Flavors & Fragrances Inc. in the app for interactive charts and portfolio building.

More in Basic Materials

Linde plc (LIN) Southern Copper Corporation (SCCO) Newmont Corporation (NEM) Freeport-McMoRan Inc. (FCX) The Sherwin-Williams Company (SHW) Ecolab Inc. (ECL)